Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Biological Efficacy of Natural Products against Noncommunicable Diseases"
A special issue of Medicines (ISSN 2305-6320).
Deadline for manuscript submissions: closed (31 July 2019).
According to the World Health Organization, noncommunicable diseases (NCDs), including cardiovascular diseases, cancers, respiratory diseases and diabetes, are responsible for almost 70% of all deaths worldwide. The rapid rise of NCDs has been driven by a number of (modifiable) behavioral risk factors, such as unhealthy diets, physical inactivity, exposure to tobacco smoke and the harmful use of alcoholic beverages, in addition to environmental (air pollutants), occupational (carcinogens, particulates, gases, fumes) and metabolic (hypertension, overweight/obesity, hyperglycemia, hypercholesterolemia) risk factors. Nowadays, the epidemic of NCDs poses devastating health consequences for individuals, families and communities, threatening to overwhelm health systems, particularly in low-income countries.
In this complex scenario, innovative therapeutic approaches are more than ever of paramount importance, including the use of natural products as the lead compounds for drug discovery, adjuvant agents in combination with conventional therapeutics to increase efficacy and/or reduce adverse effects, chemosensitizers or radiosensitizers in anticancer therapies. It is noteworthy that the rationale for using natural products relies on their multitarget mechanisms of action, which are of particular interest in the treatment of diseases with a multistage pathogenesis.
In this very wide context, we invite investigators to submit both original research and review articles that explore all these aspects, including preclinical (in vitro/in vivo) and in human studies (clinical trials, epidemiological studies, systematic reviews and meta-analyses).
Potential topics include, but are not limited to: formulation, evaluation of efficacy and mechanism of action, oral bioavailability, pharmacokinetics and the pharmacodynamics of natural products.
Dr. Sara Vitalini
Prof. Dr. Marcello Iriti
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- chronic degenerative diseases
- medicinal plants
- herbal remedies
- bioactive phytochemicals
- marine drugs
- fungal metabolites
- animal metabolites